HALOZYME THERAPEUTICS, INC.

Licenses a drug delivery platform to biopharma, converting IV drugs to subcutaneous injections.

HALO | NDAQ

Overview

Corporate Details

ISIN(s):: US40637H1095
LEI:
Country:: United States of America
Address:: 12390 EL CAMINO REAL, 92130 SAN DIEGO
Website:: https://www.halozyme.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Halozyme Therapeutics, Inc. is a biotechnology company focused on its proprietary drug delivery technology platform, ENHANZE®. This technology facilitates the subcutaneous (under-the-skin) delivery of injectable drugs and biologics that are often administered intravenously. Halozyme licenses its ENHANZE® technology to global biopharmaceutical companies, enabling them to develop new formulations of their therapies. This model aims to reinvent the patient experience by reducing treatment burden and shortening administration times, particularly in therapeutic areas such as oncology. The company's commercial portfolio is primarily built on royalties and milestone payments derived from its partners' sales of products utilizing the ENHANZE® platform.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all HALOZYME THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HALOZYME THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for HALOZYME THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
NATIONAL RESEARCH CORP AI-powered platform with analytics to measure and improve the healthcare experience for everyone.	United States of America	NRC
NATURAL RESOURCE PARTNERS LP Manages and leases a diverse portfolio of mineral and energy properties for royalty income.	United States of America	NRP
NATURECELL CO.,LTD. Biotech company developing stem cell therapies, food, beverages, and cosmetics.	South Korea	007390
Nautilus Biotechnology, Inc. Developing a proteomics platform for single-molecule analysis to advance life sciences research.	United States of America	NAUT
NEO MARKETING INC. A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.	Japan	4196
Neonode Inc. Licenses optical sensing and computer vision for HMI in automotive and consumer electronics.	United States of America	NEON
Neovacs Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.	France	ALNEV
New Frontier Minerals Limited Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.	Australia	NFM
NexGen Energy Ltd. Uranium exploration company developing a high-grade mine to supply global clean energy fuel.	United States of America	NXE
Nexxen International Ltd. End-to-end programmatic ad platform for advertisers, agencies, & publishers, specializing in video & CTV.	United States of America	NEXN